RESEARCH TRIANGLE PARK, NC, Nov. 5, 2020 — Pappas Capital, a leading venture capital firm focused on advancing life sciences, today announced that its portfolio company, VelosBio Inc. (“VelosBio” or the...
TargeGen successfully completed enrollment of a multi-center clinical trial of TG101348
© 2021 Pappas Capital, LLC. ALL RIGHTS RESERVED.